(a)

general surveillance requirements based on:

(b)

specific surveillance requirements:

(a)

general surveillance requirements based on:

(b)

specific surveillance requirements:

(a)

kept animals of listed species;

(b)

wild animals of listed species if:

(a)

they are moved to establishments in another Member State, zone or compartment; and

(b)

due to the number of animals or the frequency of the movements, the competent authority considers the animals to constitute a risk that might impair the health status of other kept animals in another Member State, zone or compartment, should a disease emerge in that species.

(a)

Union surveillance programmes;

(b)

compulsory or optional eradication programmes or surveillance necessary for the granting or maintenance of a disease-free status; or

(c)

surveillance-based animal health requirements for the movements within the Union or the entry into the Union.

(a)

with the specific legislation adopted in accordance with Regulation (EU) 2016/429 and the relevant details and guidance made available on the websites of the European Union Reference Laboratories (EURL) and of the Commission;

(b)

when not covered by the legislation, details and guidance referred to in point (a), with the collection of samples, the techniques, validation and interpretation of the diagnostic methods laid down in the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the World Organisation for Animal Health (OIE) (‘the Terrestrial Manual’ (21) as amended or the Manual of Diagnostic Tests for Aquatic Animals of the OIE (‘the Aquatic Manual’ (22) as amended;

(c)

when not covered by points (a) and (b) of this paragraph, with the methods laid down in point (b) of Article 34(2) and Article 34(3) of Regulation (EU) 2017/625.

(a)

Section 1 of Annex III for infection with Brucella abortus, B. melitensis and B.suis;

(b)

Section 2 of Annex III for infection with Mycobacterium tuberculosis complex (Mycobacterium bovis, M.caprae and M. tuberculosis) (MTBC);

(c)

Section 3 of Annex III for enzootic bovine leukosis (EBL);

(d)

Section 4 of Annex III for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis (IBR/IPV);

(e)

Section 5 of Annex III for infection with Aujeszky’s disease virus (ADV);

(f)

Section 6 of Annex III for bovine viral diarrhoea (BVD);

(g)

point 2 of Section 5 of Chapter 1 of Part II of Annex VI for viral haemorrhagic septicaemia (VHS);

(h)

point 2 of Section 5 of Chapter 1 of Part II of Annex VI for infectious haematopoietic necrosis (IHN);

(i)

point 2 of Section 5 of Chapter 2 of Part II of Annex VI for infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV);

(j)

point 2 of Section 5 of Chapter 3 of Part II of Annex VI for infection with Marteilia refringens;

(k)

point 2 of Section 5 of Chapter 4 of Part II of Annex VI for infection with Bonamia exitiosa;

(l)

point 2 of Section 5 of Chapter 5 of Part II of Annex VI for infection with Bonamia ostreae;

(m)

point 2 of Section 5 of Chapter 6 of Part II of Annex VI for infection with white spot syndrome virus (WSSV).

(a)

ante-mortem and post-mortem inspections;

(b)

inspections at border control posts;

(c)

official controls and other official activities at markets and assembly operations;

(d)

official controls and other official activities during transport of live animals;

(e)

public health related inspections and sampling in establishments;

(f)

any other official controls during which establishments, animals or samples are inspected or examined.

(a)

immediately in case of a category A disease or of an emerging disease;

(b)

without delay for other diseases.

(a)

there is a need to determine the health status of the Member State, zone or compartment thereof; or

(b)

there is a need to collect necessary information on the occurrence of the disease for any of the following purposes:

(a)

clinical, post-mortem or laboratory examinations conclude that clinical sign(s), post-mortem lesion(s) or histological findings are indicative of that disease;

(b)

result(s) from a diagnostic method are indicating the likely presence of the disease in a sample from an animal or from a group of animals; or

(c)

an epidemiological link with a confirmed case has been established.

(a)

the disease agent, excluding vaccine strains, has been isolated in a sample from an animal or from a group of animals;

(b)

an antigen or nucleic acid specific to the disease agent that is not a consequence of vaccination has been identified in a sample from an animal or from a group of animals showing clinical signs consistent with the disease or an epidemiological link with a suspected or confirmed case; or

(c)

a positive result from an indirect diagnostic method that is not a consequence of vaccination has been obtained in a sample from an animal or from a group of animals showing clinical signs consistent with the disease or an epidemiological link with a suspected or confirmed case.

(a)

it poses a particular threat to animal and possibly human health on the whole Union territory with possible serious economic consequences for the farming community and the wider economy;

(b)

it is susceptible to an evolution of the disease profile, in particular with regard to the risk for human health and animal health;

(c)

infected wild animals pose a particular threat for the introduction of the disease into a part or the whole of the Union territory;

(d)

it is fundamental to obtain, through surveillance, regularly updated information on the evolution of its circulation and on the characterisation of the disease agent, to assess those risks and adapt risk mitigating measures accordingly.

(a)

description of the epidemiological situation of the disease before the date of the beginning of the implementation of the programme and data on the epidemiological evolution of the disease;

(b)

targeted animal population, epidemiological units and zones of the programme;

(c)

organisation of the competent authority, supervision of the implementation of the programme, official controls to be applied during the implementation of the programme and the role of all relevant operators, animal health professionals, veterinarians, animal health laboratories and other natural or legal persons concerned;

(d)

description and demarcation of the geographical and administrative areas in which the programme is to be implemented;

(e)

indicators to measure the progress of the programme;

(f)

diagnostic methods used, number of samples tested, frequency of testing and sampling patterns;

(g)

risk factors to be considered for the design of a risk-based targeted surveillance.

(a)

the description of the measures implemented and the results obtained based on the information referred to in point (b) and points (d) to (f) of paragraph 1; and

(b)

the results of the follow-up of the epidemiological evolution of the disease in case of a suspected or confirmed case.

(a)

the territory and animal population covered by the eradication programme as provided for in Article 13(1);

(b)

the duration of the eradication programme as provided for in Article 15, including its final and intermediate targets as provided for in Article 14; and

(c)

the disease specific requirements laid down:

(a)

the territory covered; and

(b)

the targeted animal population and, as necessary, additional animal populations.

(a)

the entire territory of the Member State; or

(b)

one or several zones, provided that each zone corresponds to administrative unit(s) of at least 2 000 km2 and includes at least one of the regions established in accordance with Article 21 of Regulation (EU) 2016/429.

(a)

a minimum surface not significantly lower than 2 000 km2; or

(b)

the existence of natural barriers relevant to the disease profile.

(a)

all of the disease specific requirements referred to in paragraph 1; and

(b)

if necessary, additional requirements that are not included in the criteria for granting disease-free status to assess progress towards eradication.

(a)

infection with Brucella abortus, B. melitensis and B. suis;

(b)

infection with MTBC;

(c)

EBL;

(d)

IBR/IPV;

(e)

infection with ADV;

(f)

BVD.

(a)

the implementation of disease specific measures laid down in Articles 18 to 31 until all relevant establishments reach disease-free status;

(b)

the granting, suspension and withdrawal by the competent authority of the disease-free status of all relevant establishments;

(c)

the implementation of biosecurity and other risk mitigating measures;

(d)

the optional implementation of vaccination programmes.

(a)

for infection with Brucella abortus, B. melitensis and B. suis, kept bovine animals, kept ovine animals and kept caprine animals;

(b)

for infection with MTBC, kept bovine animals.

(a)

for EBL, kept bovine animals;

(b)

for IBR/IPV, kept bovine animals;

(c)

for infection with ADV, kept porcine animals;

(d)

for BVD, kept bovine animals.

(a)

general requirements:

(b)

disease specific requirements laid down in:

(a)

Sections 3 and 4 of Chapters 1 and 2 of Part I of Annex IV for infection with Brucella abortus, B. melitensis and B. suis;

(b)

Sections 3 and 4 of Chapter 1 of Part II of Annex IV for infection with MTBC;

(c)

Sections 3 and 4 of Chapter 1 of Part III of Annex IV for EBL;

(d)

Sections 3 and 4 of Chapter 1 of Part IV of Annex IV for IBR/IPV;

(e)

Sections 3 and 4 of Chapter 1 of Part V of Annex IV for infection with ADV;

(f)

Sections 3 and 4 of Chapter 1 of Part VI of Annex IV for BVD.

(a)

the details of the testing regime, including as necessary, the disease specific requirements referred to in point (b) of Article 18(1) when the disease-free status is suspended or withdrawn; and

(b)

the maximum period of time during which disease-free status may be suspended where there is a breach of the conditions referred to in paragraph 2.

(a)

has submitted for the consideration of the competent authority the information about the different epidemiological units established within the establishment to be granted distinct health status prior to any suspicion or confirmation of the disease in accordance with Articles 21 and 24;

(b)

has set up a system, to which the competent authority has access upon request, to trace the movements of animals and germinal products to, from and between the epidemiological units; and

(c)

has separated the epidemiological units by physical and management means and complies with any risk mitigating measures requested by the competent authority for that purpose.

(a)

shall prohibit movement of animals from the relevant targeted animal population out of the establishment unless it has authorised their immediate slaughter in a designated slaughterhouse;

(b)

shall, when it considers it necessary for the control of the risk of spreading the disease:

(a)

relevant additional animal populations kept in the establishment;

(b)

any establishment which has an epidemiological link with the establishment where the suspected case occurred.

(a)

the animals shall only be moved by direct transport;

(b)

in the establishment of destination, the animals shall be kept in closed facilities, with no contact with kept animals of a higher health status or with wild animals of listed species for the relevant disease.

(a)

suspend the disease-free status of the establishment of destination of the animals that are subject to the derogations, until the end of the investigations referred to in Article 21(1);

(b)

prohibit, until the end of the investigations referred to in Article 21(1), the movement of animals from that establishment, unless it has authorised their direct transport to a designated slaughterhouse for immediate slaughter;

(c)

in case of suspicion of infection with Brucella abortus, B. melitensis and B. suis or with MTBC, maintain the prohibition laid down in point (b) after the end of the investigation until all the animals that moved in the establishment following the derogation laid down in paragraph 2 have been slaughtered.

(a)

apply appropriate biosecurity and other risk mitigating measures necessary to prevent the spread of the disease; and

(b)

provide the competent authority with guarantees that all the necessary biosecurity and other risk mitigating measures have been taken.

(a)

withdraw the disease-free status of the infected establishment(s);

(b)

adopt the measures laid down in Articles 25 to 31 in the infected establishment(s).

(a)

order relevant disease control measures as provided for in Articles 21 to 25 and in Article 30 in establishments keeping the targeted animal population and the additional animal populations;

(b)

conduct or order other proportionate and necessary prevention, surveillance and disease control measures with respect to the relevant wild animal population or in its habitat.

(a)

conduct an epidemiological enquiry;

(b)

conduct investigations and apply the measures laid down in Article 21 in all epidemiologically linked establishments; and

(c)

adapt the surveillance to the identified risk factors, taking into account the conclusions of the epidemiological enquiry.

(a)

operators and relevant authorities from the Member States concerned by the epidemiological links with the confirmed case; and

(b)

the competent authorities from other Member States or third countries that may be concerned by the epidemiological links with the infected establishment(s).

(a)

order the isolation of the suspected and confirmed cases in the establishment where technically possible;

(b)

restrict the movements of animals from targeted animal population within the establishment;

(c)

restrict the introduction of animals from targeted animal population in the establishment;

(d)

restrict the movement of products of animals from targeted animal population from and to the infected establishment.

(a)

testing of those animals whose testing is considered necessary to complete the epidemiological enquiry;

(b)

testing to restore the disease-free status as laid down in:

(c)

any additional testing it considers necessary to ensure the swift detection of infected animals that may contribute to the spreading of the disease.

(i)

point 2 of Section 1 of Chapters 1 and 2 of Part I of Annex IV for infection with Brucella abortus, B. melitensis and B. suis;

(ii)

point 2 of Section 1 of Chapter 1 of Part II of Annex IV for infection with MTBC;

(iii)

point 2 of Section 1 of Chapter 1 of Part III of Annex IV for EBL;

(iv)

point 2 of Section 1 of Chapter 1 of Part IV of Annex IV for IBR/IPV;

(v)

point 2 of Section 1 of Chapter 1 of Part V of Annex IV for infection with ADV;

(vi)

point 2 of Section 1 of Chapter 1 of Part VI of Annex IV for BVD.

(a)

milk from confirmed cases shall either be fed only to animals in the same establishment after it has been processed to ensure the inactivation of the disease agent, or it shall be disposed of;

(b)

manure, straw, feed or any other matter and substance which has come into contact with a confirmed case or with contaminated material shall be either collected and disposed of as soon as possible or, following an appropriate risk assessment, stored and processed to reduce to an acceptable level the risk of spreading of the disease.

(a)

the movement does not jeopardise the health status of animals at the establishment of destination or enroute to that destination;

(b)

the animals shall only be moved by direct transport; and

(c)

in the establishment of destination, the animals shall be kept, in closed facilities, with no contact with kept animals of a higher health status or with wild animals of listed species for the relevant disease.

(a)

they are moved, if necessary by direct transport, to an establishment located in an area that is neither disease-free nor covered by an optional eradication programme; and

(b)

the movement does not jeopardise the health status of targeted or additional animal populations at the establishment of destination or enroute to that destination.

(a)

order the movement of the animals by direct transport, within a maximum period of time it determines, from the establishment of destination to a designated slaughterhouse for immediate slaughter; or

(b)

in case of a category C disease order the disease control measures laid down in Articles 26 to 30 until the disease-free status of the establishment is regained.

(a)

apply appropriate biosecurity and other risk mitigating measures necessary to prevent the spread of the disease; and

(b)

provide the competent authority with the guarantees that all the necessary biosecurity and other risk mitigating measures have been taken.

(a)

all parts of the establishments that may have been contaminated after the removal of the confirmed and suspected cases and before repopulation;

(b)

any feed, materials, substances, husbandry related equipment, medicinal equipment and production related equipment that may have been contaminated;

(c)

any protective clothing or safety equipment used by operators and visitors;

(d)

all means of transport, containers and equipment after the transport of animals or products from infected establishments;

(e)

loading areas for animals after each use.

(a)

vaccination of the animals from the targeted animal population that it considers relevant;

(b)

implementation of measures to reduce the risk of contact with infected animals;

(c)

control of the risk of spread and introduction of the disease in the territory of its Member State.

(a)

based on a risk assessment, updated, as necessary, according to the evolution of the epidemiological situation;

(b)

supported by public information campaigns involving all relevant stakeholders;

(c)

coordinated, if necessary, with relevant authorities in charge of public health, wild animal populations or hunting;

(d)

scaled according to a territorial risk-based approach.

(a)

conduct surveillance of infection with RABV for the purposes of:

(b)

carry out disease control measures in the event of suspicion or confirmation of infection with RABV as laid down in Articles 35 and 36;

(c)

apply, if necessary, risk mitigating measures to prevent the spread of RABV by movements of dogs, cats and ferrets.

(a)

vaccination, and the monitoring of the effectiveness of vaccination, in accordance with Section 2 of Chapter 1 of Part I of Annex V of wild foxes and, if relevant, of other animals referred to in Article 33(3);

(b)

the identification and registration of dogs, cats and ferrets;

(c)

movement restrictions of relevant kept animals of species referred to in Article 33(3) that are not vaccinated against infection with RABV in accordance with Section 1 of Chapter 1 of Part I of Annex V;

(d)

the measures provided for in Article 35 when an animal of a listed species wounded a person or an animal without an understandable reason and in contradiction with its normal behaviour or presented an unexplained change in behaviour followed by death within 10 days.

(a)

surveillance of infection with BTV in accordance with the requirements set out in Chapter 1 of Part II of Annex V;

(b)

vaccination of the relevant targeted animal population for eradicating the disease by means of regular vaccination campaigns to be implemented, as relevant, in accordance with a long-term strategy;

(c)

movement restrictions of the targeted animal population in accordance with the requirements laid down in Articles 43 and 45;

(d)

risk mitigating measures to minimise transmission of infection with BTV through vectors.

(a)

it shall detect and eradicate all the serotypes 1-24 present in the territory covered by the eradication programme;

(b)

the territory covered by the eradication programme shall be:

(a)

the geographical situation of the infected establishment(s) and the boundaries of the corresponding administrative units;

(b)

the ecological and meteorological conditions;

(c)

the abundance, activity and distribution of the vectors present in the zone(s);

(d)

the BTV serotype involved;

(e)

the results of the epidemiological enquiry provided for in Article 42;

(f)

the results of the surveillance activities.

(a)

comply with the requirements ordered by the competent authority as regards the surveillance of animals from the targeted animal population;

(b)

comply with the requirements ordered by the competent authority as regards the entomological surveillance;

(c)

have animals from the targeted animal population vaccinated following the orders of the competent authority;

(d)

implement disease control measures in the event the disease is suspected or confirmed following the orders of the competent authority;

(e)

comply with movement requirements following the orders of the competent authority;

(f)

implement any additional measures considered necessary by the competent authority which may include, if relevant, protection of kept animals from attacks by vectors in accordance with the animals’ health status.

(a)

comply with the requirements ordered by the competent authority as regards the surveillance of animals from the targeted animal population;

(b)

implement disease control measures in the event the disease is suspected or confirmed following the orders of the competent authority;

(c)

implement any additional measures considered necessary by the competent authority which may include, if relevant, protection of kept animals from attacks by vectors in accordance with the animals’ health status.

(a)

map the territory covered in a set of geographical units in accordance with point 1 of Section 4 of Chapter 1 of Part II of Annex V;

(b)

conduct surveillance of infection with BTV in each geographical unit, as relevant with regard to the epidemiological situation, according to the requirements laid down in Chapter 1 of Part II of Annex V;

(c)

apply the disease control measures laid down in Articles 41 and 42 in the event of suspicion or confirmation of the disease;

(d)

order operators of establishments of bovine, ovine or caprine animals and, if necessary, other targeted animal populations to have their animals vaccinated; and

(e)

apply the requirements laid down in Articles 43 and 45 to the movements of animals from the targeted animal population.

(a)

information demonstrating the fulfilment of the specific criteria for determining the seasonally BTV-free period;

(b)

the start and end dates of the period;

(c)

information demonstrating the cessation of the transmission of BTV in the area; and

(d)

the delimitation of the area which complies with the minimum requirements laid down in Article 13.

(a)

restrict movement of animals and germinal products from the targeted animal population from the establishment where they are kept unless authorised for the purpose of immediate slaughter;

(b)

order relevant risk mitigating measures, when necessary and technically feasible, to prevent or reduce exposure of animals from the targeted animal population to attacks by vectors.

(a)

confirm the outbreak and, if necessary, establish or extend the zone under eradication programme;

(b)

conduct an epidemiological enquiry, if necessary;

(c)

restrict movement of animals of the targeted animal population from the establishment where they are kept unless authorised for the purpose of immediate slaughter;

(d)

restrict movement of germinal products of animals from the targeted animal population from the establishment where they are kept;

(e)

order relevant risk mitigating measures, when it considers it necessary and technically feasible, to prevent or reduce exposure of animals from the targeted animal population to attacks by vectors;

(f)

apply the disease control measures provided for in Article 41 to all establishments having an epidemiological link with the confirmed case, including those keeping animals from the targeted animal population having a similar exposure to infectious vectors to that of the confirmed case.

(a)

order operators of establishments of bovine, ovine or caprine animals and, if necessary, other targeted animal populations to have their animals vaccinated against the infection with the relevant BTV serotype(s) as provided for in point (d) of Article 40(1);

(b)

investigate and monitor the health status of the targeted animal population in the proximity of the establishment where the confirmed case is kept.

(a)

it has assessed the risk that the introduction poses to the health status of the place of destination as regards infection with BTV, taking into account possible risk mitigating measures it may adopt at the place of destination;

(b)

it prohibits the movement of these animals to another Member State:

(c)

it adapts, if necessary, the surveillance in accordance with point 6 of Section 4 of Chapter 1 of Part II of Annex V; and

(d)

the animals comply with any one of the requirements set out in points 5 to 8 of Section 1 of Chapter 2 of Part II of Annex V.

(a)

it has assessed the risk that the introduction poses to the health status of the place of destination as regards infection with BTV, taking into account possible risk mitigating measures it may adopt at the place of destination;

(b)

it prohibits the movement of these germinal products to another Member State; and

(c)

the germinal products comply with the requirements set out in point 4 of Section 2 of Chapter 2 of Part II of Annex V.

(a)

inform the Commission thereof as soon as possible;

(b)

accept animals or germinal products from the targeted animal population that comply with the requirements for the relevant derogation regardless of the Member State or zone of origin of the animal or germinal products.

(a)

the animals from the targeted animal population comply with at least one of the requirements set out in points 1 to 3 of Section 1 of Chapter 2 of Part II of Annex V; or

(b)

the means of transport onto which the animals are loaded have been protected from attacks by vectors and the journey does not include the unloading of the animals for a period longer than 1 day, or the animals are unloaded for a period longer than 1 day in a vector protected establishment or during the vector-free period.

(a)

the type of surveillance requirements necessary to achieve the conditions for granting and maintaining disease-free status taking into account point (b)(ii) of Article 3(2);

(b)

the territory and animal population covered by the eradication programme as provided for in Articles 47 and 51;

(c)

the duration of the eradication programme provided for in Article 49 including its final and intermediate targets as provided for in Article 48;

(d)

the disease specific preventive and control measures laid down in Articles 55 to 65.

(a)

the territory covered; and

(b)

the targeted animal population and, if necessary, additional animal populations.

(a)

the entire territory of the Member State;

(b)

one or several zones; or

(c)

the geographical location of the establishments of which the compartment or compartments are comprised.

(a)

all of the disease specific requirements referred to in paragraph 1 and the targets provided for in paragraph 2; and

(b)

if necessary, additional requirements that are not included in the requirements for granting disease-free status to assess progress towards eradication.

(a)

Chapter 1 for VHS and IHN;

(b)

Chapter 2 for infection with HPR-deleted ISAV;

(c)

Chapter 3 for infection with Marteilia refringens;

(d)

Chapter 4 for infection with Bonamia exitiosa;

(e)

Chapter 5 for infection with Bonamia ostreae;

(f)

Chapter 6 for infection with WSSV.

(a)

pose a significant risk to the health status of animals referred to in paragraph 1;

(b)

are included due to the small number of aquaculture establishments in the eradication programme and when their inclusion is necessary to obtain a satisfactory epidemiological coverage of the Member State, zone or compartment.

(a)

the health status of each establishment as known at the time the eradication programme commences;

(b)

the compliance with conditions for the introduction of animals from listed species into the establishment;

(c)

the compliance by the operator with the obligation to notify the competent authority of any suspicion or detection of the disease;

(d)

the fulfilment of disease control measures to be applied if the disease is suspected or confirmed;

(e)

the vaccination regimes that may apply to animals from listed species kept in the establishment;

(f)

any additional measures considered necessary by the competent authority.

(a)

commence, maintain, or withdraw the eradication programme according to the compliance or non-compliance of establishments with the requirements laid down in paragraph 1;

(b)

inform the operators of the relevant establishments about the evolution of the health status and the necessary measures for granting disease-free status.

(a)

prohibit the introduction of animals or products of animal origin into the establishment;

(b)

where technically possible, order the isolation of units in the establishment where suspected animals are kept;

(c)

prohibit the movement of animals and products of animal origin out of the establishment unless authorised by the competent authority for the purpose of immediate slaughter or processing in a disease control aquatic food establishment, or for direct human consumption in the case of molluscs or crustacea which are sold live for that purpose;

(d)

prohibit the movement of equipment, feed and animal by-products from the establishment unless authorised by the competent authority.

(a)

any establishment which due to hydrodynamic conditions, has an increased risk of contracting the disease from the suspected establishment;

(b)

any establishment which has a direct epidemiological link with the suspected establishment.

(a)

only animals showing no symptoms of disease are moved;

(b)

the health status of aquaculture animals at the establishment of destination or aquatic animals enroute to that establishment is not jeopardised by the movement;

(c)

in the establishment of destination they have no contact with aquaculture animals of a higher health status with respect to the relevant disease; and

(d)

the animals are kept in the establishment of destination for a maximum period of time to be determined by the competent authority.

(a)

re-classify the health status of the establishment of destination, if relevant, in accordance with the criteria laid down in Article 52(1), until the end of the investigation referred to in Article 55(1);

(b)

prohibit the movement of animals from the establishment of destination until the end of the investigation, unless it has authorised their transport to a disease control aquatic food establishment for immediate slaughter or processing or for direct human consumption, in the case of molluscs or crustacea which are sold live for that purpose.

(a)

apply appropriate biosecurity and other risk mitigating measures necessary to prevent the spread of the disease;

(b)

provide the competent authority with guarantees that all the necessary biosecurity and other risk mitigating measures have been taken; and

(c)

provide the competent authority with guarantees that animal by-products as defined in point (1) of Article 3 of Regulation (EC) No 1069/2009 from the aquatic animals referred to in paragraph 1(c) of this Article are processed or disposed of as Category 1 or Category 2 material in accordance with Articles 12 or 13 of that Regulation.

(a)

declare the establishment(s) infected;

(b)

reclassify the health status of the infected establishment(s);

(c)

establish a restricted zone which is of an appropriate size;

(d)

adopt the measures laid down in Articles 59 to 65 in the infected establishment(s).

(a)

point 1(a) of Section 3 of Chapter 1 for VHS and IHN;

(b)

point 1(a) of Section 3 of Chapter 2 for infection with HPR-deleted ISAV;

(c)

point 1(a) of Section 3 of Chapter 3 for infection with Marteilia refringens;

(d)

point 1(a) of Section 3 of Chapter 4 for infection with Bonamia exitiosa;

(e)

point 1(a) of Section 3 of Chapter 5 for infection with Bonamia ostreae;

(f)

point 1(a) of Section 3 of Chapter 6 for infection with WSSV.

(a)

when an infected establishment does not discharge untreated effluent into surrounding waters; and

(b)

where the biosecurity measures which exist at the establishment are of a standard which ensures that infection is fully contained within it.

(a)

the movement of well-boats through the restricted zone;

(b)

fishing activities;

(c)

other activities that may pose a risk of disease spread.

(a)

develop and implement the prevention, surveillance and disease control measures that are necessary to prevent the spread of the disease to kept animals of listed species or to additional animal populations;

(b)

apply intensified surveillance of wild aquatic animal populations and in establishments having a direct epidemiological link with the confirmed case;

(c)

take measures to eradicate the disease from the relevant wild aquatic animal population, where feasible.

(a)

conduct an epidemiological enquiry;

(b)

conduct investigations and apply the measures laid down in Article 55(2) in all epidemiologically linked establishments;

(c)

adapt the surveillance to the identified risk factors, taking into account the conclusions of the epidemiological enquiry.

(a)

operators and relevant authorities from the Member State concerned by the epidemiological links with the confirmed case; and

(b)

the competent authorities from other Member States or third countries that may be concerned by the epidemiological links with the infected establishment(s).

(a)

where technically possible, order the isolation of suspected and confirmed cases;

(b)

prohibit the movement of animals or products of animal origin from the listed species for the relevant disease out of the establishment(s) unless authorised by the competent authority for immediate slaughter or processing in a disease control aquatic food establishment or for direct human consumption in the case of molluscs or crustacea which are sold live for that purpose;

(c)

prohibit the introduction of animals from the listed species for the relevant disease to the establishment(s) unless authorised by the competent authority on duly justified grounds;

(d)

prohibit the movement of equipment, feed and animal by-products from the establishment(s) unless authorised by the competent authority.

(a)

only animals showing no symptoms of disease are moved;

(b)

the health status of aquaculture animals at the establishment of destination or aquatic animals enroute to that establishment is not jeopardised by the movement;

(c)

in the establishment of destination they have no contact with aquaculture animals of a higher health status with respect to the relevant disease;

(d)

the animals are kept in the establishment of destination for a maximum period of time to be determined by the competent authority.

(a)

re-classify the health status of the establishment of destination, if relevant, in accordance with the criteria laid down in Article 52(1);

(b)

prohibit the movement of animals from the establishment of destination, unless it has authorised their transport to a disease control aquatic food establishment for immediate slaughter or processing or for direct human consumption, in the case of molluscs or crustacea which are sold live for that purpose. In all cases, animal by- products as defined in point (1) of Article 3 of Regulation (EC) No 1069/2009 shall be processed or disposed of as Category 1 or Category 2 material in accordance with Articles 12 or 13 of that Regulation.

(c)

keep the establishment of destination under its official supervision until the completion of cleaning, disinfection and appropriate fallowing of the establishment.

(a)

only animals showing no symptoms of disease are moved;

(b)

the health status of aquaculture animals at the establishment of destination or aquatic animals enroute to that establishment is not jeopardised by the movement; and

(c)

the movement complies with the certification requirements set out in Article 208(2) of Regulation (EU) 2016/429.

(a)

only animals showing no symptoms of disease are moved;

(b)

the slaughtering and processing facility is not located in a Member State, zone or compartment which is implementing an eradication programme for that specific disease or which has been declared disease-free;

(c)

the health status of aquatic animals enroute for the slaughtering and processing facility or in its vicinity is not jeopardised by the movement;

(d)

the movement complies with the certification requirements set out in Article 208(2) of Regulation (EU) 2016/429.

(a)

a risk assessment has been completed;

(b)

risk mitigating measures are implemented, where necessary, to ensure that the health status of the aquatic animals at the establishment of destination or enroute to that destination is not jeopardised; and

(c)

the movement complies with the certification requirements set out in Article 208(2) of Regulation (EU) 2016/429.

(a)

removal of all dead animals;

(b)

removal and killing of all moribund animals;

(c)

removal and killing of all animals showing symptoms of disease;

(d)

slaughtering for human consumption, or in the case of molluscs or crustacea which are sold live, removal from the water of the animals that remain at the establishment(s) after the measures in points (a) to (c) have been completed.

(a)

all animals from listed species for the relevant disease in the infected establishment(s), without testing these animals;

(b)

suspected animals which have an epidemiological link with a confirmed case.

(a)

the establishments, in so far as this is technically possible, after the removal of the animals referred to in Article 62(1) and of all feed that may have been contaminated;

(b)

any husbandry related equipment including but not limited to feeding, grading, treatment and vaccination equipment, and workboats;

(c)

any production related equipment including but not limited to cages, netting, trestles, bags and longlines;

(d)

any protective clothing or safety equipment used by operators and visitors;

(e)

all means of transport including tanks and other equipment used to move infected animals or personnel who have been in contact with infected animals.

(a)

point 1(c) of Section 3 of Chapter 1 for VHS and IHN;

(b)

point 1(c) of Section 3 of Chapter 2 for infection with HPR-deleted ISAV;

(c)

point 1(c) of Section 3 of Chapter 3 for infection with Marteilia refringens;

(d)

point 1(c) of Section 3 of Chapter 4 for infection with Bonamia exitiosa;

(e)

point 1(c) of Section 3 of Chapter 5 for infection with Bonamia ostreae;

(f)

point 1(c) of Section 3 of Chapter 6 for infection with WSSV.

(a)

point 1 of Section 3 of Chapter 1 for VHS and IHN;

(b)

point 1 of Section 3 of Chapter 2 for infection with HPR-deleted ISAV;

(c)

point 1 of Section 3 of Chapter 3 for infection with Marteilia refringens;

(d)

point 1 of Section 3 of Chapter 4 for infection with Bonamia exitiosa;

(e)

point 1 of Section 3 of Chapter 5 for infection with Bonamia ostreae;

(f)

point 1 of Section 3 of Chapter 6 for infection with WSSV.

(a)

the general criteria laid down in point (a)(i) and (a)(ii) of Article 66 have been fulfilled for an eligibility period of at least 5 years and the disease was not detected; and

(b)

the listed species relevant to the disease in question are absent from kept and wild animal populations.

(a)

the likelihood of the presence of animals from listed species in the Member State’s territory or a zone thereof was assessed and was found to be negligible; and

(b)

the likelihood of introduction of animals from listed species into the Member State’s territory or a zone thereof was found to be negligible.

(a)

the general criteria laid down in points (a)(i) and (a)(ii) of Article 66 have been fulfilled for an eligibility period of at least 5 years and the disease was not detected;

(b)

the disease has never been reported or, if reported, it has been demonstrated that the disease agent did not survive;

(c)

the value of at least one critical environmental parameter that is not compatible with the survival of the disease agent is reached;

(d)

the disease agent is exposed to that critical environmental parameter for a period of time that is sufficient to destroy it.

(a)

with respect to the fulfilment of the criteria set out in points (a) and (b) of paragraph 1, documentary evidence;

(b)

with respect to the fulfilment of the criteria set out in points (c) and (d) of paragraph 1, scientific evidence.

(a)

the general criteria laid down in points (a)(i) and (a)(ii) of Article 66 have been fulfilled for an eligibility period of at least 5 years and the disease was not detected;